Systematic review / meta-analysis / 2021
Curcuminoids improved knee osteoarthritis pain more than comparators, with no significant differences between high and low doses.
A systematic review and meta-analysis of 11 randomized controlled trials including 1,258 participants evaluated the effects of curcuminoids in primary knee osteoarthritis. Curcuminoids were significantly more effective than comparators for VAS and WOMAC pain scores, and a significant difference in VAS pain was found when comparing curcuminoids to NSAIDs. No significant differences in pain relief or adverse events were observed between high-dose (daily ≥1000 mg or total ≥42 gm) and low-dose (<1000 mg/day or <42 gm total) treatments. Three included studies comparing curcuminoids to NSAIDs reported higher adverse event rates with NSAIDs, reaching significance in one study.
- Study type
- Systematic review and meta-analysis of RCTs
- Who was studied
- 1,258 participants with primary knee osteoarthritis across 11 studies
- What was measured
- Pain relief (VAS and WOMAC pain scores), functional improvement, and adverse events
THE PAPER
The efficacy of high- and low-dose curcumin in knee osteoarthritis: A systematic review and meta-analysis.
Hsiao AF, Lien YC, Tzeng IS, Liu CT, Chou SH, Horng YS. Complement Ther Med, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.